Is RYZB or SPHD a better dividend investment in 2026?

RYZB currently yields 3.20% with a 5% 5-year dividend growth rate. SPHD yields 4.00% with 5% growth. The better choice depends on your goal: SPHD offers higher current income.

What is the dividend yield difference between RYZB and SPHD?

RYZB has a forward dividend yield of 3.20% ($2.00/share annually). SPHD yields 4.00% ($2.00/share annually). The yield gap is 0.80 percentage points.

Home › Compare › RYZB vs SPHD

RYZB vs SPHD: Dividend Comparison 2026

RYZB yields 3.20% · SPHD yields 4.00%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SPHD wins by $3.5K in total portfolio value

INVESTMENT

TIME HORIZON10 years

RYZB

● Live price

3.20%

Share price

$62.49

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$24.6K

Annual income

$393.29

Full RYZB calculator →

SPHD

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$28.0K

Annual income

$899.19

Full SPHD calculator →

Portfolio growth — RYZB vs SPHD

📍 SPHD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RYZB	SPHD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RYZB + SPHD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RYZB pays

SPHD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RYZB

Annual income on $10K today (after 15% tax)

$272.04/yr

After 10yr DRIP, annual income (after tax)

$334.30/yr

SPHD

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$764.31/yr

At 15% tax rate, SPHD beats the other by $430.02/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RYZB + SPHD for your $10,000?

RYZB: 50%SPHD: 50%

100% SPHD50/50100% RYZB

Portfolio after 10yr

$26.3K

Annual income

$646.25/yr

Blended yield

2.46%

📊

Analyst Conviction Gap

Where Wall Street is split right now

RYZB

Analyst Ratings

Hold

Consensus: Hold

SPHD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RYZB buys

SPHD buys

No recent congressional trades found for RYZB or SPHD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRYZBSPHD

Forward yield	3.20%	4.00% ✓
Annual dividend / share	$2.00	$2.00
Payout ratio	50%	50%
1-year div growth	0%	5% ✓
5-year div CAGR	0%	5% ✓
Portfolio after 10y	$24.6K	$28.0K ✓
Annual income after 10y	$393.29	$899.19 ✓
Total dividends collected	$3.6K	$6.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: RYZB vs SPHD ($10,000, DRIP)

Year	RYZB Portfolio	RYZB Income/yr	SPHD Portfolio	SPHD Income/yr	Gap
1← crossover	$11,020	$320.05	$11,120	$420.00	$100.00 → SPHD
2	$12,121	$329.62	$12,357	$458.31	$236.00 → SPHD
3	$13,308	$338.84	$13,721	$499.76	$413.00 → SPHD
4	$14,588	$347.69	$15,227	$544.58	$639.00 → SPHD
5	$15,965	$356.18	$16,885	$593.02	$920.00 → SPHD
6	$17,447	$364.31	$18,713	$645.34	$1.3K → SPHD
7	$19,040	$372.08	$20,724	$701.81	$1.7K → SPHD
8	$20,753	$379.49	$22,938	$762.73	$2.2K → SPHD
9	$22,592	$386.56	$25,372	$828.41	$2.8K → SPHD
10	$24,566	$393.29	$28,047	$899.19	$3.5K → SPHD

RYZB vs SPHD: Complete Analysis 2026

RYZB — Stock

RayzeBio, Inc. develops radiopharmaceutical therapeutics (RPT) for the treatment of cancer. The company’s lead drug candidate is RYZ101, which is in phase 3 clinical trial for the treatment of gasteroenteropancreatic neuroendocrine tumors (GEP-NETs). It also develops RYZ801, a novel proprietary peptide that targets GPC3 for delivery of Ac225 for the treatment of hepatocellular carcinoma (HCC); RYZ811, a paired diagnostic imaging agent with the peptide binder, chelator, and Ga68 as the radioisotope; and a novel proprietary small molecule that targets CA9 for delivery of Ac225 for the treatment of ccRCC. The company was incorporated in 2020 and is based in San Diego, California.

Full RYZB Calculator →

SPHD — ETF

SPHD is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in SPHD shares.

Full SPHD Calculator →

📬

Get this RYZB vs SPHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RYZB vs SCHD RYZB vs JEPI RYZB vs O RYZB vs KO RYZB vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.